Visual Function After Implantation of AcrySof® Toric Lens
ClinicalTrials.gov ID
NCT01074606
Lead Sponsor
Alcon ResearchINDUSTRY
Overall Status
Terminated
Study Type
Interventional
Phase
Phase 4
Enrollment
56Actual
Last Update Posted
Sep 19, 2012Estimated
Start Date
Jan 2010
Primary Completion Date
Mar 2011Actual
Brief Summary
The objective of this study is to evaluate the postoperative visual function of Taiwanese patients following bilateral or unilateral AcrySof Toric Intraocular Lens (IOL) implantation.
Cataract
AcrySof Toric Intraocular Lens
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Prospective subjects should be adults and may be of any race and gender, and diagnosed with cataracts.
Subject must require extraction of cataracts followed by implantation of a posterior chamber intraocular lens.
All subjects must have between 0.75 - 2.0 Diopter (D) of astigmatism preoperatively as measured by keratometry readings.
For any second eye surgery in bilateral AcrySof Toric patients, it should be performed at least one week following the first eye implant but no longer than one month after the first implant.
Exclusion Criteria:
Subjects with pre-existing conditions that could skew the results should be excluded from the Study.
AcrySof® Toric product inserts under "Precautions" for subject groups that should be excluded from this Study.